Status:

COMPLETED

Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Adolescent Smokers

Lead Sponsor:

National Institute on Drug Abuse (NIDA)

Conditions:

Nicotine Dependence

Eligibility:

All Genders

13-17 years

Brief Summary

Background: * Multiple social, psychological, and environmental factors contribute to adolescents' use of cigarettes. Environmental smoking cues have been shown to play an important role in the maint...

Detailed Description

Objective: To determine the effects of smoking versus neutral cues in adolescents who smoke on 1) craving, mood, and autonomic responsivity and 2) the relative reinforcing efficacy of tobacco cigaret...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • 13-17 year old males and females
  • smoking at least 5 cigarettes per day for at least 6 months
  • urinary cotinine level greater than or equal to 100 ng/ml (NicAlert(Registered Trademark) reading greater than or equal to 3)
  • medically and psychologically healthy as determined by screening criteria.
  • EXCLUSION CRITERIA:
  • current interest in reducing or quitting smoking
  • treatment for nicotine dependence in the past 3 months
  • use of nicotine replacement products, bupropion, or varenicline in the past 3 months
  • alcohol and any illicit drug use more than 7 times in the last 14 days
  • current use of any medication that would interfere with the protocol in the opinion of MAI
  • pregnant, nursing, or become pregnant during the study

Exclusion

    Key Trial Info

    Start Date :

    June 10 2008

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    January 14 2011

    Estimated Enrollment :

    25 Patients enrolled

    Trial Details

    Trial ID

    NCT01148355

    Start Date

    June 10 2008

    End Date

    January 14 2011

    Last Update

    July 2 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institute on Drug Abuse, Biomedical Research Center (BRC)

    Baltimore, Maryland, United States, 21224